sc0r3-4dm1n
-
The pharmaceutical sector is comforting itself with a myth.
The narrative goes like this: “Access to physicians is declining, so we need more digital and more omnichannel.” It sounds logical. It feels modern. But it is fundamentally wrong. Let’s clear up the confusion: The real problem is much more uncomfortable. Doctors aren’t unreachable—we are just becoming irrelevant. Physicians don’t need more information; they are already drowning…
-
Complexe medische informatie omzetten in video voor meer impact
Hoe breng jij waardevolle informatie goed over? Herken je dit? Je hebt belangrijke medische informatie. Waardevol, complex en essentieel om goed over te brengen. Maar je doelgroep — zorgverleners, specialisten, patiënten — heeft minder tijd dan ooit. Lange teksten worden gescand, presentaties half gevolgd. En de boodschap? Die gaat vaak verloren. En daar maken wij…
-
Van marktdruk naar nieuwe groei
Hoe breng jij je product weer in de spotlight? Herken je dit? Je product draait al even mee, maar de markt begint te schuren. Een concurrent gooit de prijzen omlaag, het patent van de concurrent verloopt, of de doelgroep kijkt opeens een andere kant op. Hoe blijf je relevant? Nou, daar kunnen wij bij helpen.…
-
The Science of Marketing: Why Pharma Needs to Move from “Selling” to “Solving”
Effective advertising is deeply rooted in neuroscience, specifically targeting the amygdala and the hippocampus. Working together within the limbic system, these two structures process emotions and encode memories, forming the foundation of emotional memory. Consequently, campaigns tied to authentic emotion inherently drive higher engagement and positive brand association. A prime example of this is HEMA’s…
-
Beyond the Product Plan: Why Modern Pharma Engagement Demands a Consumer-First Mindset
Audience engagement is built on a universal truth: stakeholders are inherently receptive to communication, provided the content offers tangible and relevant value. To understand this dynamic, we need only evaluate our own behaviour as everyday consumers. Navigating a landscape of persistent information overload, we routinely form definitive conclusions based on immediate first impressions. This mirrors…
-
What do you do when you realize people don’t read ads?
Should you change your messaging? Or do you need to replace your communication channels entirely? First, let’s look at the brutal reality of the attention economy: We are trapped in a relentless, exhausting battle for customer attention. Stop Broadcasting. Start Designing.This information overload forces us to abandon traditional “push” marketing. We must start thinking like…
-
The First Date Rule of Pharma Marketing
Everyone is open to connecting—if the content and solutions are relevant and valuable. It sounds like an open door but look at your own behaviour as a consumer. We are all drowning in information overload. We make split-second, definitive judgments about new brands based on a single first impression. Think of it like dating. If…
-
Orphan Drug Marketing: Why the Traditional Pharma Playbook Fails
Launching a therapy in the rare disease space sounds attractive. But the reality? It’s a completely different playing field than mainstream pharma. You aren’t dealing with mass markets. You are dealing with tiny patient populations, highly specialized centres of excellence, and deeply committed physicians. Prescriptions don’t happen daily; they happen in critical, rare windows. To…
-
The Mediocrity Trap: Why Corporate Self-Protection is Killing Pharma Innovation
There is a profound paradox at the heart of modern corporate culture. Organizations frequently declare a strategic desire for internal entrepreneurs, agile thinkers who challenge conventions and venture off established tracks. Yet, when innovative concepts are introduced, they are routinely stifled by institutional inertia, risk aversion, and bureaucratic compliance. This corporate friction is rarely malicious;…
-
Pharma Marketing has a definition problem.
True marketing is simply the act of telling a story that people want to hear. Yet, the traditional pharma playbook does the exact opposite. Global campaigns routinely push out rigid product features long before the audience is ready to hear them. The real challenge isn’t the data, it’s the delivery. HCPs are now completely self-directed;…